Insider Trading: Insys Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

38.75USD
21 Nov 2014
Price Change (% chg)

$-0.22 (-0.56%)
Prev Close
$38.97
Open
$39.25
Day's High
$39.30
Day's Low
$38.53
Volume
59,229
Avg. Vol
124,003
52-wk High
$57.91
52-wk Low
$20.52

Search Stocks
FOURTEAU PATRICK P
Trading Date Type Shares Traded Price Shares Held
18 Nov 2014 Sell 25,000 $39.11 80,000
14 May 2014 Buy 4,500 $22.95 105,000
14 May 2014 Buy 3,000 $22.50 105,000
13 Aug 2013 Buy 5,000 $23.77 65,000
13 May 2013 Buy 5,000 $10.90 60,000
12 May 2013 Buy 2,000 $11.10 55,000
8 May 2013 Buy 2,800 $10.75 55,000
7 May 2013 Buy 200 $10.40 50,200
6 May 2013 Buy 37,500 $8.00 50,000
6 May 2013 Buy 12,500 $9.45 50,000

Institutional Holders

% Shares Owned: 40.42%
# of Holders: 153
Total Shares Held: 14,130,981
3 Mo. Net Change: 2,392,894
# New Positions: 31
# Closed Positions: 19
# Increased Positions: 81
# Reduced Positions: 61
# Net Buyers: 20

Officers & Directors

Name Age Since Current Position

John Kapoor

70 2006 Executive Chairman of the Board

Michael Babich

37 President, Chief Executive Officer, Director

Darryl Baker

45 2012 Chief Financial Officer

Patrick Fourteau

66 2011 Independent Director

Pierre Lapalme

73 2011 Independent Director

Steven Meyer

2010 Independent Director

Theodore Stanley

73 2013 Independent Director

Brian Tambi

68 2010 Independent Director
Search Stocks